Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 15, 2018
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
[ Thu, Mar 15th 2018
] - WOPRAI
Wed, March 14, 2018
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
Tue, March 13, 2018
[ Tue, Mar 13th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
David Nierengarten Maintained (SYRS) at Buy with Increased Target to $130 on, Mar 13th, 2018
David Nierengarten of Wedbush, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Increased Target from $110 to $130 on, Mar 13th, 2018.
David, nor any peers, have made any analyst calls on SYRS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Similar Stocks and Investing Articles
[ Tue, Mar 06th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Tue, Nov 14th 2017
] - WOPRAI
[ Fri, Nov 03rd 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Thu, Oct 26th 2017
] - WOPRAI
[ Fri, Oct 13th 2017
] - WOPRAI
[ Fri, Jan 23rd 2015
] - WOPRAI
[ Tue, Jan 20th 2015
] - WOPRAI
[ Mon, Aug 13th 2012
] - WOPRAI